Common ground and continued debate: further response to “Strong evidence against PRP injections for chronic lateral epicondylar tendinopathy: a systematic review”

The rich academic discussion continues! Here is a Letter to the Editor from Renee Keijsers, Denise Eygendaal, Michel P. J. van den Bekerom that they wrote in response to a blog from RJ de Vos and colleagues (read it here), who wrote an initial Letter to the Editor (read it here) in response to: Robert-Jan de Vos, Johann […]

Read More…

De Vos, Windt and Weir respond to: “Should we really abandon PRP in the treatment of lateral epicondylar tendinopathy?”

One of the great things about social media (blogs, Twitter, etc.) is that it encourages dynamic dialogue and discussion. Academics and practitioners alike benefit from the new insights and ‘food for thought’ this generates. With this tenet in mind, here is a letter from Robert-Jan de Vos, Johann Windt and Adam Weir in response to the BJSM blog: Should we really […]

Read More…

No magical therapeutic benefit of PRP in Achilles tendinopathy — JAMA paper follow-up and BJSM podcast

My sense is that the popularity of platelet-rich plasma (PRP) is increasing independent of research in this field. BJSM has covered this with front cover attention: Platelet-rich plasma: Debate. Jul 2010, (44)9 IOC consensus paper on the use of platelet-rich plasma in sports medicine. Dec 2010, (44)15 Of most interest to blog readers will be […]

Read More…

The PRP debate.

Achilles Tendinopathy is a major clinical problem. Injections with Platelet-Rich Plasma (PRP) improve tissue repair and tendon structure. PRP also increases blood supply to the tendon collagen tissue by stimulating blood vessels to grow. But, what does this mean for patients with Achilles Tendinopathy? What are the functional outcomes: Does it restore the tendon to its pre-injury […]

Read More…